Back to top Open menu arrow
Purchase PDF

Save Save

Cite Cite

Reprints
Sections
METHODS RESULTS DISCUSSION CONCLUSION Clinical Points
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

Systematic Review Focus on Women’s Mental Health October 26, 2022

Relationship of Premenstrual Dysphoric Disorder With Bipolar Disorder: A Systematic Review

; ;

J Clin Psychiatry 2022;83(6):22r14416

ABSTRACT

Objective: Since depression represents the most predominant mood polarity in bipolar disorder (BD), the prevalence rates of a diagnosis of premenstrual dysphoric disorder (PMDD) in women with BD and those of a diagnosis of BD in women with PMDD deserve systematic review.

Data Sources: A systematic search of PubMed, EMBASE, CINAHL, PsycINFO, and Cochrane Reviews databases was carried out on November 19, 2021, using the terms [late luteal phase disorder OR premenstrual dysphoric disorder] AND comorbidity AND bipolar disorder. Articles from 1987–2021 were searched. Case studies, intervention studies, reviews, and systematic analyses were excluded.

Study Selection: All studies that included a diagnosis of PMDD and BD were included.

Data Extraction: The selected articles were reviewed to extract data using a data extraction form developed for this study.

Results: A total of 5 studies were included in the review. Extant literature, although limited, suggests that PMDD is more common among women with BD than in the general population. Similarly, BD is more common among women with PMDD than in the general population. The proportion of people with PMDD and diagnosed with BD ranged from 10% to 15%. Conversely, the proportion of people with BD who received a diagnosis of PMDD ranged from 27% to 76%.

Conclusions: Only a small number of relevant studies were available, and the findings from these were limited by the failure to employ prospective monitoring of symptoms—perhaps the most important feature necessary for confirming PMDD and differentiating it from premenstrual exacerbation of BD. Given the important clinical and heuristic implications, prospective studies are needed to clarify the relationship between the two disorders in order to improve their detection, diagnosis, and treatment.

Continue Reading...

Members enjoy unlimited free PDF downloads as part of their subscription! Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Buy PDF for $40

Please sign in or purchase this PDF for $40.

  1. Yonkers K, Casper R. Epidemiology and pathogenesis of premenstrual syndrome and premenstrual dysphoric disorder. UpToDate website. https://www.uptodate.com/contents/epidemiology-and-pathogenesis-of-premenstrual-syndrome-and-premenstrual-dysphoric-disorder. 2015.
  2. de Carvalho AB, Cardoso TA, Mondin TC, et al. Prevalence and factors associated with premenstrual dysphoric disorder: a community sample of young adult women. Psychiatry Res. 2018;268:42–45. PubMed CrossRef
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Publishing, Inc; 2013.
  4. Wittchen H-U, Becker E, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32(1):119–132. PubMed CrossRef
  5. Heinemann LA, Do Minh T, Filonenko A, et al. Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life. Patient. 2010;3(2):125–132. PubMed CrossRef
  6. Heinemann LA, Minh TD, Heinemann K, et al. Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities. Health Care Women Int. 2012;33(2):109–124. PubMed CrossRef
  7. Reid RL, Soares CN. Premenstrual dysphoric disorder: contemporary diagnosis and management. J Obstet Gynaecol Can. 2018;40(2):215–223. PubMed CrossRef
  8. Andreano JM, Touroutoglou A, Dickerson B, et al. Hormonal cycles, brain network connectivity, and windows of vulnerability to affective disorder. Trends Neurosci. 2018;41(10):660–676. PubMed CrossRef
  9. Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018;218(1):68–74. PubMed CrossRef
  10. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV. Washington, DC: American Psychiatric Association; 1994.
  11. O’Brien PM, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Women Ment Health. 2011;14(1):13–21. PubMed CrossRef
  12. Reed GM, First MB, Kogan CS, et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry. 2019;18(1):3–19. PubMed CrossRef
  13. Cirillo PC, Passos RB, Bevilaqua MC, et al. Bipolar disorder and premenstrual syndrome or premenstrual dysphoric disorder comorbidity: a systematic review. Br J Psychiatry. 2012;34(4):467–479. PubMed CrossRef
  14. Dias RS, Lafer B, Russo C, et al. Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry. 2011;168(4):386–394. PubMed CrossRef
  15. Blehar MC, DePaulo JR Jr, Gershon ES, et al. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull. 1998;34(3):239–243. PubMed
  16. Slyepchenko A, Frey BN, Lafer B, et al. Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1,099 women from STEP-BD study. Acta Psychiatr Scand. 2017;136(5):473–482. PubMed CrossRef
  17. Fornaro M, Perugi G. The impact of premenstrual dysphoric disorder among 92 bipolar patients. Eur Psychiatry. 2010;25(8):450–454. PubMed CrossRef
  18. Sepede G, Brunetti M, Di Giannantonio M. Comorbid premenstrual dysphoric disorder in women with bipolar disorder: management challenges. Neuropsychiatr Dis Treat. 2020;16:415–426. PubMed CrossRef
  19. Carvalho AF, Dimellis D, Gonda X, et al. Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry. 2014;75(6):e578–e586. PubMed CrossRef
  20. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet. 2009;25(2):99–105. PubMed CrossRef
  21. McEvoy K, Osborne LM, Nanavati J, et al. Reproductive affective disorders: a review of the genetic evidence for premenstrual dysphoric disorder and postpartum depression. Curr Psychiatry Rep. 2017;19(12):94. PubMed CrossRef
  22. Slyepchenko A, Minuzzi L, Frey BN. Comorbid premenstrual dysphoric disorder and bipolar disorder: a review. Front Psychiatry. 2021;12:719241. PubMed CrossRef
  23. Moher D, Shamseer L, Clarke M, et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. PubMed CrossRef
  24. Hardoy MC, Serra M, Carta MG, et al. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder. J Clin Psychopharmacol. 2006;26(4):379–384. PubMed CrossRef
  25. Wittchen HU, Pfister H. Instruktionsmanual zur durchführung von DIA-X interviews. Swets & Zeitlinger; 1997.
  26. World Health Organization. Composite International Diagnostic Interview (CIDI). Geneva: WHO; 1990.
  27. Pereira D, Pessoa AR, Madeira N, et al. Association between premenstrual dysphoric disorder and perinatal depression: a systematic review. Arch Women Ment Health. 2022;25(1):61–70. PubMed CrossRef
  28. Keramatian K, Pinto JV, Schaffer A, et al. Clinical and demographic factors associated with delayed diagnosis of bipolar disorder: data from Health Outcomes and Patient Evaluations in Bipolar Disorder (HOPE-BD) study. J Affect Disord. 2022;296:506–513. PubMed CrossRef
  29. Osborn E, Wittkowski A, Brooks J, et al. Women’s experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation. BMC Womens Health. 2020;20(1):242. PubMed CrossRef
  30. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–468. PubMed CrossRef
  31. Nevatte T, O’Brien PM, Bäckström T, et al; Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Arch Women Ment Health. 2013;16(4):279–291. PubMed CrossRef
  32. Aalouane R, Rammouz I, Elghazouani F, et al. Hypomanic episodes during menstrual periods: bipolar II disorder? Psychiatry Clin Neurosci. 2011;65(1):112–113. PubMed CrossRef
  33. Parry BL, Ehlers CL, Mostofi N, et al. Personality traits in LLPDD and normal controls during follicular and luteal menstrual-cycle phases. Psychol Med. 1996;26(1):197–202. PubMed CrossRef
  34. Millon T. Millon Clinical Multiaxial Inventory. Minneapolis: National Computer Systems; 1977.
  35. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530–537. PubMed CrossRef
  36. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60(3):261–269. PubMed CrossRef
  37. Cohen LS, Soares CN, Otto MW, et al; The Harvard Study of Moods and Cycles. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. J Affect Disord. 2002;70(2):125–132. PubMed CrossRef
  38. Ogasawara K, Nakamura Y, Kimura H, et al. Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5. J Neural Transm (Vienna). 2018;125(2):211–222. PubMed CrossRef
  39. Teatero ML, Mazmanian D, Sharma V. Effects of the menstrual cycle on bipolar disorder. Bipolar Disord. 2014;16(1):22–36. PubMed CrossRef
  40. Karadag F, Akdeniz F, Erten E, et al. Menstrually related symptom changes in women with treatment-responsive bipolar disorder. Bipolar Disord. 2004;6(3):253–259. PubMed CrossRef
  41. Robakis TK, Holtzman J, Stemmle PG, et al. Lamotrigine and GABAA receptor modulators interact with menstrual cycle phase and oral contraceptives to regulate mood in women with bipolar disorder. J Affect Disord. 2015;175:108–115. PubMed CrossRef
Buy PDF for $40

Please sign in or purchase this PDF for $40.

Save Save

Cite Cite

Vol 86 • 2025 • Number 1

Read the Current Issue

Original Research

Psychological Support in Psychedelic Therapy

Original Research

Long-Term Safety and Efficacy of Esmethadone in MDD

Original Research

Suicidal Behaviors and Obstructive Sleep Apnea

Editorial

A Collaborative Endeavor

Brief Report

Sex Differences in PTSD among US Military Veterans

Clinical and Practical Psychopharmacology

Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes in Children and Young Adults
View current Issue

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe